The research of Sanghuangporusbaumii tablets on immune regulation of colorectal cancer patients after chemotherapy

Interventions: Experimental group:OralSanghuangporusbaumii tablets (15g per person per day, 200ml of boiling water for 15min, filter out the supernatant, then 200ml of boiling water for 15min, filter out the supernatant, combine the two supernatants for oral use), continuous treatment for 2 weeks;Positive control group:The patient was treated with thymofaxine (1.6 mg subcutaneously twice a week) for 2 consecutive weeks. Primary outcome(s): Immunocompromised control ratio;Immune function index;Adverse reactions;Symptom score Study Design: Parallel